P386 A target 6-thioguanine nucleotide ≥125 is associated with a higher rate and longer durability of response in infliximab–thiopurine combination therapy: a retrospective study in Crohn's disease patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.